Abstract
Xeroderma pigmentosum (XP) is a group of genetic diseases with high incidence of ultraviolet-related skin cancers that usually appear in childhood. Treatment options for skin cancer in XP include surgery, electrocoagulation, topical 5-fluorouracil or imiquimod 5% cream1. Oral retinoids have been used for skin cancer prevention, alone or in combination with topical imiquimod, with good response2.
This article is protected by copyright. All rights reserved.
http://ift.tt/2GsRVhV
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου